although it has the advantage of being given orally, seems less effective, and ampicillin similarly. Comparative statistical evidence of the value of the various penicillins and of the antibiotics is not available, and would be difficult to obtain, but I have no personal doubt that at present in the acute infection methicillin and chloramphenical are the two most effective drugs.
A major anxiety is the development of bacterial resistance in the child with repeated or persistent infection. This develops sooner or later in all these children and makes the continued prophylactic use of antibiotics unwise.
An antibiotic free from this drawback would be of the greatest value: in about 12 children with cystic fibrosis treated for up to one year with daily fucidin I have as yet had no case of drug resistance. But this may in any case not develop with any drug given prophyllactically for a year or more.
For the pseudomonas there appears to be no 'answer at present, whether the antibiotic is given by mouth, injection or by aerosol. We have used four of these new penicillins (methicillin, nafcillin, oxacillin and cloxacillin) in the treatment of about 500 patients with staphylococcal infections, half of whom had failed to respond to therapy with other antibiotics.
Staphylococci resistant to penicillin G alone or along with other micro-organisms were cultured prior to new penicillin therapy in all patients. Patients with well localized areas of suppuration without systemic reaction or without evidence of spreading infection who could be expected to respond to incision and drainage only, were not included. The conditions treated can be summarized under the following classifications:
1 If these responses were not elicited the result was considered poor. Seventy-eight per cent of patients with a variety of staphylococcal infections responded to therapy with the new antistaphylococcal penicillins.
For the purpose of this discussion I should like to deal in greater detail with the use of the new penicillins in the treatment of staphylococcal enterocolitis, septicemia and certain types of soft tissue infections.
Enterocolitis
Thirteen patients with staphylococcal enterocolitis had received prior broad spectrum antibiotic therapy either in the form of tetracycline or neomycin sulfate and phthalylsulfathiazole (Sulfathalidine) Figure 2 shows the result of oxacillin therapy in a patient who developed staphylococcal enterocolitis while receiving neomycin. Figure 3 shows the postoperative progress of an 84-year-old patient who developed staphylococcal enterocolitis after operation and showed a good response to oxacillin.
Septicemia
Twenty-one patients with a clinical diagnosis of septicemia received oxacillin. sites of the infection included the skin, lungs, the wound, an indwelling intravenous polyethylene catheter, deep soft tissue abscess, the heart (endocarditis), and an aortic prosthesis. All were acutely ill with fever, leukocytosis, and other signs of acute systemic infection. Fourteen of the 21 patients had failed to respond to prior antibiotic therapy. In all patients staphylococci were isolated from the blood. The critically ill patients received oxacillin or methicillin intravenously for the first 48 to 96 hours. L arger doses of methicillin than oxacillin were required. Subsequently, the drug was given intramuscularly (0.5 to 1.0 g. every 4 to 6 hours). Four received oxacillin intramuscularly from the beginning of therapy. Duration of therapy ranged from 10 to 20 days in most instances.
Fifteen of the 21 patients responded to therapy. The blood was sterilized and there was no recurrence within a six to ten week period of observation. In one patient the result was indeterminate because of concurrent therapy with chloramphenicol. 5) . He failed to respond to penicillin G, erythromycin, and chloramphenicol given concurrently. He was critically ill with intermittent fever to 104'F., and coagulase-positive Staph. aureus was cultured from his blood. Methicillin (20 g./day in divided doses, was given intravenously for two days and intramuscularly (12 g./day in divided doses) for seven days. Thereafter, he showed sterilization of the blood and gradual subsidence of the signs and symptoms of his infection. Methicillin therapy was continued intramuscularly for 25 additional days with a gradual decrease in the daily dose. He was cured after 34 days of treatment with a total dose of 274 g. (Fig. 7) .
Case 4. A 61-year-old patient with hypertension and renal failure due to "allergic" vasculitis developed suppurative lesions of the buttock, presacral area and elbow while receiving corticosteroids. Staphylococci were cultured from his wounds as well as his blood. After 24 hours of methicillin therapy (Fig. 8) Another illustrative case is that of a 67-yearold diabetic with a history of chronic recurrent furunculosis who developed a giant staphylococcal carbuncle in the left posterior chest. He had failed to respond to incision and drainage and therapy with penicillin G, streptomycin, erythromycin, tetracycline and chloramphenicol. After 24 hours of methicillin therapy the suppurative lesion was widely excised. Methicillin therapy was continued and two weeks thereafter closure of the clean wound was accomplished with the aid of a split thicklness skin graft. His recovery was uneventful.
In these patients with recurrent staphylococcal infections new penicillin administration for 15 to 120 days was required. After initial clearance with the first course of therapy, recurrences were seen in about 10% and these patients required an additional course of therapy. Thereafter, these patients and those who responded to the initial course of therapy remained free from infection for the six to 12 months of follow-up observations.
Discussion
From the use of these four synthetic penicillins in a large group of patients with various types of staphylococcal infections, the following impressions have emerged:
(1) All are effective in vitro and in vivo against penicillinase producing staphylococci and most other common gram positive bacteria.
(2) Oxacillin appears to be the most effective agent for intramuscular or intravenous injection in the treatment of infections due to penicillin G-resistant staphylococci. In vitro and pharmacological data suggest that parenteral oxacillin is superior to methicillin largely because of the lower amounts of the drug required.
(3) Cloxacillin is most useful for oral use and yields more regular absorption thian oxacillin and nafcillin and more uniform and higher serum levels. It appears to be superior to oxacillin because of better and more uniform absorption after ingestion, lower degradation by the liver and possibly greater resistance to penicillinase hydrolysis than other synthetic penicillins (Bunn and Milicich, 1963; Gravenkemper, Sweedler, Brodie, Sidell and Kirby, 1963) . Although the new penicillins are also effective against certain other gram-positive bacteria such as streptococci and pneumococci on a weight basis, they are less active against these micro-organisms than is penicillin G. Staphylococci resistant to penicillin G required higher concentrations of oxacillin, methicillin, cloxacillin or nafcillin for inhibition than did penicillin G sensitive staphylococci, pneumococci and certain sensitive strains of streptococci. Therefore, the new penicillins are not the drugs of choice for the treatment of infections due to grampositive bacteria other than penicillinaseproducing staphylococci. However, doses recommended for the control of infections due to the latter micro-organisms are sufficiently large to also control infections due to pneumococci, penicillin G-sensitive staphylococci and most strains of streptococci. The new penicillins are ineffective against gram negative bacteria and most strains of Strept.
fecalis.
As with other antibiotics the new penicillins are effective in the treatment of surgical infections of the soft tissues if coupled with appropriate surgical management. After removal of foreign bodies, drainage of abscesses, and debridement of necrotic tissue the recovery of many critically ill patients furnished evidence of the considerable efficacy of the supportive value of these drugs. High dosage and prolonged therapy are sometimes required, par- Apart from children with simple asthmatic attacks we see many children with recurrent bronchial infections especially during the winter months.
In Holland it is a widely used practice to protect such children during the winter months by continuous administration of sulphonamides. However, we found that about one third of all the pneumococci isolated from such patients proved to be resistant to sullphonamides, and this 'has been confirmed by other Dutch investigators.
In our first trial 75 children were studied, their ages ranging from four to twelve years. They had all suffered for at least a year from recurrent infections of the lower respiratory tract with an allergic basis. The children concerned are all selected cases as we accepted only those patients referred from the general outpatient clinic which were judged to be serious enough to be treated by our special team. All the children were first examined by the E.N.T. specialist, and were vaccinated with influenza virus vaccine.
The patients were distributed at random over three groups of similar age and comparable living conditions. The prophylactic treatment was given each morning before 'breakfast. Group one consisted of 24 children taking propicillin (125 mgms.), Group two, 26 children taking sulphadimidine (500 mgms.), and Group three 25 children taking a placebo (one tablet each morning). The experiment was organised on a double-blind basis. Every child was examined at least once a month.
The results of the prophylactic treatment were judged mainly from the number and severity of the respiratory infections developed by the children. Infection was judged on the basis of the findings in the sputum, X-ray examination and 'physical examination. A secondary criterion was the general impression gained by the parents of the child's condition in the period of treatment as compared to that in the previous year or years.
